You have 9 free searches left this month | for more free features.

Amrubicin

Showing 1 - 20 of 20

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Small Cell Lung Cancer (SCLC) Trial (Tarlatamab, Lurbinectedin, Topotecan)

Not yet recruiting
  • Small Cell Lung Cancer (SCLC)
  • (no location specified)
Feb 21, 2023

Advanced Solid Tumors Trial in United States (Amrubicin)

Completed
  • Advanced Solid Tumors
  • Amrubicin
  • La Jolla, California
  • +7 more
Oct 30, 2019

Small Cell Lung Cancer Trial in Worldwide (Amrubicin, Cisplatin, Etoposide)

Completed
  • Small Cell Lung Cancer
  • Amrubicin
  • +2 more
  • Antwerpen, Belgium
  • +24 more
Nov 14, 2019

Thymoma, Thymus Cancer, Thymic Carcinoma Trial in Stanford, Indianapolis (Amrubicin)

Completed
  • Thymoma
  • +2 more
  • Amrubicin
  • Stanford, California
  • +1 more
Apr 5, 2019

Small Cell Lung Cancer Trial in Netherlands, United Kingdom, United States (Amrubicin)

Completed
  • Small Cell Lung Cancer
  • Amrubicin
  • Phoenix, Arizona
  • +45 more
Oct 16, 2019

Lung Cancer Trial in Worldwide (Nivolumab, Topotecan, Amrubicin)

Active, not recruiting
  • Lung Cancer
  • Little Rock, Arkansas
  • +149 more
Apr 7, 2022

Multiple Myeloma Trial in Stanford (Amrubicin, Lenalidomide, Dexamethasone)

Completed
  • Multiple Myeloma
  • Amrubicin
  • +4 more
  • Stanford, California
    Stanford University School of Medicine
Sep 17, 2018

Small Cell Lung Cancer Trial in Worldwide (Amrubicin, Topotecan)

Completed
  • Small Cell Lung Cancer
  • Muscle Shoals, Alabama
  • +139 more
Oct 30, 2019

Prophylactic Cranial Irradiation in Extensive-stage Small Cell

Recruiting
  • Extensive-stage Small-cell Lung Cancer
  • Prophylactic Cranial Irradiation
  • Beijing, Beijing, China
    Cancer Insititute and Hosiptal of Chinese Academy of Medical Sci
Sep 16, 2021

Bladder Cancer Trial in Gilbert, Indianapolis, New York (Amrubicin)

Terminated
  • Bladder Cancer
  • Amrubicin
  • Gilbert, Arizona
  • +2 more
Mar 22, 2018

Multiple Myeloma Trial in China (Lenalidomide, Dexamethasone)

Completed
  • Multiple Myeloma
  • Beijing, China
  • +10 more
Nov 7, 2019

Soft Tissue Sarcoma Trial in Santa Monica, Salt Lake City (Amrubicin)

Completed
  • Soft Tissue Sarcoma
  • Amrubicin
  • Santa Monica, California
  • +1 more
Mar 3, 2017

Extensive-Stage Small Cell Lung Cancer Trial in United States (Amrubicin, Carboplatin, Pegfilgrastim)

Completed
  • Extensive-Stage Small Cell Lung Cancer
  • Amrubicin
  • +2 more
  • Jonesboro, Arkansas
  • +19 more
Apr 1, 2016

Lung Cancer Trial in United States (Amrubicin, Cyclophosphamide)

Completed
  • Lung Cancer
  • Springdale, Arkansas
  • +9 more
Dec 21, 2015

Lung Cancer Trial in Multiple Locations (Amrubicin hydrocloride, Docetaxel)

Completed
  • Lung Cancer
  • Sites, Japan
    32 Sites
Aug 27, 2015

Small Cell Lung Cancer (SCLC) Trial in Germany, Italy, Japan (TAS-102, Amrubicin (Japan), Topotecan (Japan/Europe))

Terminated
  • Small Cell Lung Cancer (SCLC)
  • Mannheim, Baden-Württemberg, Germany
  • +22 more
Jul 11, 2014

Lung Cancer Trial in Japan (amrubicin HCl, irinotecan HCl)

Completed
  • Lung Cancer
  • amrubicin hydrochloride
  • irinotecan hydrochloride
  • Gunma, Japan
  • +6 more
May 29, 2013

Malignant Mesothelioma Trial in Worldwide (drug, procedure, radiation)

Completed
  • Malignant Mesothelioma
  • Edegem, Belgium
  • +7 more
Jul 17, 2012

Small Cell Lung Cancer Trial in United States (Amrubicin, Topotecan)

Completed
  • Small Cell Lung Cancer
  • Birmingham, Alabama
  • +46 more
Sep 28, 2009

Metastatic Breast Cancer Trial in United States (Amrubicin)

Withdrawn
  • Metastatic Breast Cancer
  • Amrubicin
  • New Milford, Connecticut
  • +27 more
Sep 22, 2008